Home > Boards > US Listed > Medical - Healthcare > Iovance BiotherapeutIcs (IOVA)

I CAN NOT BELIEVE that a Director (INSIDER)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
microcapbiotech Member Profile
 
Followed By 5
Posts 518
Boards Moderated 0
Alias Born 06/14/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/19/2019 5:17:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/19/2019 5:15:59 PM
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer GlobeNewswire Inc. - 7/18/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 8:01:29 AM
Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Adm... GlobeNewswire Inc. - 7/2/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/21/2019 4:46:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:06 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/11/2019 5:16:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 8:00:58 AM
Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors GlobeNewswire Inc. - 6/11/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 4:33:06 PM
Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating ... GlobeNewswire Inc. - 5/31/2019 7:00:00 AM
Iovance Biotherapeutics to Participate in Upcoming Conferences in June GlobeNewswire Inc. - 5/31/2019 6:59:00 AM
Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Produ... GlobeNewswire Inc. - 5/29/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 4:41:21 PM
Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patie... GlobeNewswire Inc. - 5/22/2019 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 5:22:37 PM
Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs GlobeNewswire Inc. - 5/15/2019 5:27:43 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 5:03:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:09:10 PM
Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/7/2019 4:01:00 PM
microcapbiotech   Monday, 01/07/19 05:03:08 AM
Re: None
Post # of 35 
I CAN NOT BELIEVE that a Director (INSIDER) of IOVA bought 12.5 MILLION dollars worth of shares in early December at a HIGHER price than it currently is … and NOBODY is on this board posting anything???
I bought in last week and BUYING EVEN MUCH MORE today!!!


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist